# Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour

> **NCT02615405** · NA · COMPLETED · sponsor: **National Science and Technology Council, Taiwan** · enrollment: 240 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** EPA
- **DIETARY_SUPPLEMENT:** DHA
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02615405
- **Lead sponsor:** National Science and Technology Council, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615405, "Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02615405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*